We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00772876
Recruitment Status : Completed
First Posted : October 15, 2008
Last Update Posted : November 22, 2012
Information provided by (Responsible Party):
Piramal Enterprises Limited

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2012
  Study Completion Date : May 2012
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):